On November 6, 2023, AIM ImmunoTech Inc. filed a definitive proxy statement soliciting proxies and urged the shareholders to vote for the election of the Company?s proposed nominees, Nancy K. Bryan, Thomas K. Equels, William M. Mitchell, and Stewart L. Appelrouth, as directors of the Company and to vote for the proposal to approve, by non-binding advisory vote, the compensation of our named executive officers at the Company?s annual shareholders meeting scheduled to be held on December 1, 2023.